Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin Apotheke
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in: Wiener klinische Wochenschrift 23-24/2016

01.12.2016 | case report

Nonbacterial thrombotic endocarditis presenting as intracerebral hemorrhage

verfasst von: Olivier Wigger, MD, Stephan Windecker, MD, Stefan Bloechlinger, MD, PhD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2016

Einloggen, um Zugang zu erhalten

Summary

Nonbacterial thrombotic endocarditis is a rare cause of valvular heart disease, most commonly associated with advanced malignancy. The morbidity of this kind of endocarditis lies in its tendency to embolize, while the valve function is usually preserved. The central nervous system is the most common site of embolization, leading to ischemic stroke. We report a case of nonbacterial thrombotic endocarditis complicated by intracerebral hemorrhage as the first manifestation of adenocarcinoma of the lung. The endocarditis led to severe aortic regurgitation. In view of the advanced stage of lung cancer, the patient refused further therapy. He passed away 3 weeks after first diagnosis of the adenocarcinoma.
Vorheriger Artikel Genetic testing of familial hypercholesterolemia in a real clinical setting
Nächster Artikel Adult patent ductus arteriosus
Literatur
1.
El-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist. 2007;12(5):518–23.CrossRefPubMed
2.
Deppisch LM, Fayemi AO. Non-bacterial thrombotic endocarditis: clinicopathologic correlations. Am Heart J. 1976;92(6):723–9.CrossRefPubMed
3.
Biller J, Challa VR, Toole JF, Howard VJ. Nonbacterial thrombotic endocarditis. a neurologic perspective of clinicopathologic correlations of 99 patients. Arch Neurol. 1982;39(2):95–8.CrossRefPubMed
4.
5.
Edoute Y, Haim N, Rinkevich D, Brenner B, Reisner SA. Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients. Am J Med. 1997;102(3):252–8.CrossRefPubMed
6.
Sack GH, Levin J, Bell WR. Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore). 1977;56(1):1–37.CrossRef
7.
Tiong IS, Williams MJ, Perez DJ. Nonbacterial thrombotic endocarditis with ST-elevation myocardial infarction treated with percutaneous coronary aspiration thrombectomy. Heart Lung Circ. 2013;22(5):386–9.CrossRefPubMed
8.
Yasutake H, Sugano Y, Ikeda Y, Ohara T, Hasegawa T, Kanzaki H, et al. First case report of the antemortem diagnosis of nonbacterial thrombotic endocarditis of a mechanical prosthetic valve. Intern Med. 2016;55(3):255–7.CrossRefPubMed
9.
Lee AY. Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev. 2002;28(3):137–40.CrossRefPubMed
10.
Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. Am J Cardiol. 2006;97(6):894–8.CrossRefPubMed
11.
Colchero T, Lopez-Sanchez FA, Dominguez-Perez L, Rodriguez-Padial L. Nonbacterial thrombotic endocarditis and severe aortic valve regurgitation. Resolution after chemotherapy. Med Clin (Barc). 2012;138(6):271–2.CrossRef
12.
Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349(2):146–53.CrossRefPubMed
13.
Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, et al. Antithrombotic therapy in valvular heart disease – native and prosthetic: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(457):82.
14.
Fujishima S, Okada Y, Irie K, Kitazono T, Saku Y, Utsunomiya H, et al. Multiple brain infarction and hemorrhage by nonbacterial thrombotic endocarditis in occult lung cancer – a case report. Angiology. 1994;45(2):161–6.CrossRefPubMed
Metadaten
Titel
Nonbacterial thrombotic endocarditis presenting as intracerebral hemorrhage
verfasst von
Olivier Wigger, MD
Stephan Windecker, MD
Stefan Bloechlinger, MD, PhD
Publikationsdatum
01.12.2016
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 23-24/2016
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-016-1020-y

Weitere Artikel der Ausgabe 23-24/2016

Wiener klinische Wochenschrift 23-24/2016 Zur Ausgabe

original article

Association between apolipoprotein B EcoRI polymorphisms and coronary heart disease

original article

Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease

images in clinical medicine

Adult patent ductus arteriosus

original article

Orosomucoid is an independent predictor of prognosis in chronic heart failure

MUW researcher of the month

MUW researcher of the month November 2016

original article

Perioperative erythropoietin protects the CNS against ischemic lesions in patients after open heart surgery